Tuberculosis: Immunity and Immune Evasion

NIH RePORTER · NIH · R13 · $9,000 · view on reporter.nih.gov ↗

Abstract

ABSTRACT Support is requested for a Keystone Symposia conference entitled Tuberculosis: Immunity and Immune Evasion, organized by Drs. Joel Ernst, Jennifer Philips and Daniel L. Barber. The conference will be held in Santa Fe, New Mexico USA from January 16- 20, 2020. Tuberculosis remains the most common fatal infectious disease worldwide due to the absence of a sufficiently effective vaccine. Two critical barriers to the development of an effective TB vaccine are the incomplete understanding of the mechanisms of protective immunity to TB, and of the mechanisms of immune evasion by M. tuberculosis. The interactions among speakers and attendees at this conference will promote collaborations between scientists with complementary expertise and that work in geographically distinct institutions, including those in high TB burden regions. This conference will present new knowledge on mechanisms of protective immunity to M. tuberculosis, and promote dialogue between immunologists and scientists, in different areas of expertise, to fill gaps in knowledge. Participants will also discuss advances in TB vaccine development and vaccine immunology. Finally, this conference will cover topics on the advances in other fields of immunology and other infectious diseases characterized by pathogen persistence which will help to inform development of effective TB vaccines.

Key facts

NIH application ID
9834772
Project number
1R13AI147619-01
Recipient
KEYSTONE SYMPOSIA
Principal Investigator
Thale Cross Jarvis
Activity code
R13
Funding institute
NIH
Fiscal year
2020
Award amount
$9,000
Award type
1
Project period
2019-12-01 → 2020-06-30